These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 31738427

  • 1. Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer.
    Amatu A, Sartore-Bianchi A, Bencardino K, Pizzutilo EG, Tosi F, Siena S.
    Ann Oncol; 2019 Nov 01; 30(Suppl_8):viii5-viii15. PubMed ID: 31738427
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Diagnosis and management of TRK fusion cancer.
    Kummar S, Italiano A, Brose MS, Carlson JJ, Sullivan SD, Lassen U, Federman N.
    Am J Manag Care; 2022 Jan 01; 28(2 Suppl):S15-S25. PubMed ID: 35201680
    [Abstract] [Full Text] [Related]

  • 6. The Use of Pan-Tropomyosin Receptor Kinase Immunohistochemistry as a Screening Tool for the Detection of Neurotrophic Tropomyosin-Related Kinase Fusions: Real-World Data from a National Multicentric Retrospective Study.
    Van Bockstal MR, Beniuga G, Craciun L, Creytens D, Dedeurwaerdere F, Delvenne P, Demetter P, De Wiest B, Dewinne K, Habran L, Pauwels P, Theate I, Vander Borght S, Van Der Steen K, Weynand B.
    Pathobiology; 2022 Jan 01; 89(6):393-406. PubMed ID: 35350025
    [Abstract] [Full Text] [Related]

  • 7. Identifying patients with NTRK fusion cancer.
    Solomon JP, Benayed R, Hechtman JF, Ladanyi M.
    Ann Oncol; 2019 Nov 01; 30(Suppl_8):viii16-viii22. PubMed ID: 31738428
    [Abstract] [Full Text] [Related]

  • 8. Methods for Identifying Patients with Tropomyosin Receptor Kinase (TRK) Fusion Cancer.
    Wong D, Yip S, Sorensen PH.
    Pathol Oncol Res; 2020 Jul 01; 26(3):1385-1399. PubMed ID: 31256325
    [Abstract] [Full Text] [Related]

  • 9. Tropomyosin Receptor Kinase Inhibitors for the Treatment of TRK Fusion Cancer.
    Laetsch TW, Hong DS.
    Clin Cancer Res; 2021 Sep 15; 27(18):4974-4982. PubMed ID: 33893159
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of neurotrophic tropomyosin receptor kinase (NTRK) fusion gene positivity in patients with solid tumors in Japan.
    Nakata E, Osone T, Ogawa T, Taguchi T, Hattori K, Kohsaka S.
    Cancer Med; 2024 Jun 15; 13(12):e7351. PubMed ID: 38925616
    [Abstract] [Full Text] [Related]

  • 11. Treatment Patterns of Real-World Patients with TRK Fusion Cancer Treated by US Community Oncologists.
    Klink AJ, Kavati A, Gassama A, Kozlek T, Gajra A, Antoine R.
    Target Oncol; 2022 Sep 15; 17(5):549-561. PubMed ID: 36089643
    [Abstract] [Full Text] [Related]

  • 12. Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network.
    Demetri GD, Antonescu CR, Bjerkehagen B, Bovée JVMG, Boye K, Chacón M, Dei Tos AP, Desai J, Fletcher JA, Gelderblom H, George S, Gronchi A, Haas RL, Hindi N, Hohenberger P, Joensuu H, Jones RL, Judson I, Kang YK, Kawai A, Lazar AJ, Le Cesne A, Maestro R, Maki RG, Martín J, Patel S, Penault-Llorca F, Premanand Raut C, Rutkowski P, Safwat A, Sbaraglia M, Schaefer IM, Shen L, Serrano C, Schöffski P, Stacchiotti S, Sundby Hall K, Tap WD, Thomas DM, Trent J, Valverde C, van der Graaf WTA, von Mehren M, Wagner A, Wardelmann E, Naito Y, Zalcberg J, Blay JY.
    Ann Oncol; 2020 Nov 15; 31(11):1506-1517. PubMed ID: 32891793
    [Abstract] [Full Text] [Related]

  • 13. [NTRK Fusions: A new way of treatment for gastro-intestinal tumor?].
    Ouali K, Pellat A, Cohen R, Svrcek M, Penault-Llorca F, André T.
    Bull Cancer; 2020 Apr 15; 107(4):447-457. PubMed ID: 32067719
    [Abstract] [Full Text] [Related]

  • 14. NTRK gene fusion testing and management in lung cancer.
    Repetto M, Chiara Garassino M, Loong HH, Lopez-Rios F, Mok T, Peters S, Planchard D, Popat S, Rudzinski ER, Drilon A, Zhou C.
    Cancer Treat Rev; 2024 Jun 15; 127():102733. PubMed ID: 38733648
    [Abstract] [Full Text] [Related]

  • 15. The Diagnostic Value of Pan-Trk Expression to Detect Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion in CNS Tumours: A Study Using Next-Generation Sequencing Platform.
    Mohamed F, Kurdi M, Baeesa S, Sabbagh AJ, Hakamy S, Maghrabi Y, Alshedokhi M, Dallol A, Halawa TF, Najjar AA, Fdl-Elmula I.
    Pathol Oncol Res; 2022 Jun 15; 28():1610233. PubMed ID: 35295612
    [Abstract] [Full Text] [Related]

  • 16. Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy.
    Hsiao SJ, Zehir A, Sireci AN, Aisner DL.
    J Mol Diagn; 2019 Jul 15; 21(4):553-571. PubMed ID: 31075511
    [Abstract] [Full Text] [Related]

  • 17. Emerging Targeted Therapy for Tumors with NTRK Fusion Proteins.
    Kheder ES, Hong DS.
    Clin Cancer Res; 2018 Dec 01; 24(23):5807-5814. PubMed ID: 29986850
    [Abstract] [Full Text] [Related]

  • 18. Identifying patients with NTRK fusion cancer.
    Solomon JP, Benayed R, Hechtman JF, Ladanyi M.
    Ann Oncol; 2019 Nov 01; 30 Suppl 8():viii16-viii22. PubMed ID: 32223934
    [Abstract] [Full Text] [Related]

  • 19. Tumour response to TRK inhibition in a patient with pancreatic adenocarcinoma harbouring an NTRK gene fusion.
    O'Reilly EM, Hechtman JF.
    Ann Oncol; 2019 Nov 01; 30(Suppl_8):viii36-viii40. PubMed ID: 31605106
    [Abstract] [Full Text] [Related]

  • 20. Recommended testing algorithms for NTRK gene fusions in pediatric and selected adult cancers: Consensus of a Singapore Task Force.
    Lim KHT, Kong HL, Chang KTE, Tan DSW, Tan IBH, Mohamad F, Soh SY, Pang BN, Soo RA, Choo SP, Hsieh WS, Aung L.
    Asia Pac J Clin Oncol; 2022 Aug 01; 18(4):394-403. PubMed ID: 34806337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.